Yale Smoking Cessation and Alcohol Treatment Research Clinic at CMHC
Mission
To develop and evaluate treatments for smoking and for problematic alcohol consumption.
Presently we are conducting an alcohol treatment study called the ADVANCE study.
The ADVANCE Study
This is a treatment study examining the use of Varenicline (Chantix) to reduce alcohol consumption among heavy drinkers who smoke cigarettes. Click here to go to the ADVANCE study website.
Who is eligible for the ADVANCE study?
- Adults 18-70 years old.
- Those who want to reduce or stop your alcohol use.
- Those who smoke cigarettes.
- Meet other inclusion criteria for the study.
Location
SATU
1 Long Wharf Drive, Suite 18
New Haven, CT 06511
Yale Faculty
Lisa Fucito
Assistant Professor of Psychiatry
Jolomi Ikomi
Assistant Professor of Psychiatry
Medical Director, Substance Abuse Treatment Center at CMHC
Robert Leeman, Jr
Assistant Professor of Psychiatry
Stephanie O'Malley
Professor of Psychiatry
Director, Division of Substance Abuse Research in Psychiatry
Assistant Chair, Clinical Research
Benjamin Toll
Associate Professor of Psychiatry
Program Director, Smoking Cessation Service at Smilow Cancer Hospital at Yale-New Haven
Contact Us
For more information about the ADVANCE study, call Susan at 203-974-5768 or email advance@yale.edu.
